Antibody-based cancer immunotherapy by targeting regulatory T cells
Regulatory T cells (Tregs) are among the most abundant suppressive cells, which infiltrate and accumulate in the tumor microenvironment, leading to tumor escape by inducing anergy and immunosuppression. Their presence has been correlated with tumor progression, invasiveness and metastasis. Targeting...
Main Authors: | Quanxiao Li, Jun Lu, Jinyao Li, Baohong Zhang, Yanling Wu, Tianlei Ying |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1157345/full |
Similar Items
-
Regulatory cells and the effect of cancer immunotherapy
by: María Iglesias-Escudero, et al.
Published: (2023-02-01) -
Editorial: Targeting regulatory cells in cancer: old and new approaches in immunotherapy
by: Luigi Cari, et al.
Published: (2024-07-01) -
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line
by: Alain Gelibter, et al.
Published: (2024-04-01) -
Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations
by: Junwei Ge, et al.
Published: (2024-09-01) -
A new target of radiotherapy combined with immunotherapy: regulatory T cells
by: Dongmei Song, et al.
Published: (2024-01-01)